Learn about RNA Advisors' valuation consulting team for life sciences and healthcare companies, VCs, investors and university systems. Strategic valuation assessments and opinions, financial transaction support, 409A regulatory guidance, portfolio modeling, primary/secondary research and strategic advisors for biopharma, medtech, digital health and healthcare companies across their full life cycle, from preclinical stages to exit or commercialization.